FAS and metabolic dysfunction-associated steatotic liver disease: OA administration increased the activities of FAS (89.8%, P < 0.01), ME (24.6%, P < 0.05) and G6PDH (72.8%, P < 0.05) in liver, while feeding SCC to NAFLD rats significantly abolished the OA-induced increase.